101. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients
- Author
-
Kazuto Kobayashi, Junya Aoki, Yuka Terasawa, Junichi Uemura, Shinji Yamashita, Kazumi Kimura, Noriko Matsumoto, Yasuyuki Iguchi, and Kensaku Shibazaki
- Subjects
Male ,Time Factors ,medicine.medical_treatment ,Asymptomatic ,Magnetic resonance angiography ,Fibrinolytic Agents ,Predictive Value of Tests ,Humans ,Medicine ,Prospective Studies ,cardiovascular diseases ,Stroke ,Aged ,Cerebral Hemorrhage ,Retrospective Studies ,Aged, 80 and over ,Intracerebral hemorrhage ,medicine.diagnostic_test ,business.industry ,T-plasminogen activator ,Cerebral infarction ,Thrombolysis ,medicine.disease ,nervous system diseases ,Diffusion Magnetic Resonance Imaging ,Logistic Models ,Neurology ,Tissue Plasminogen Activator ,Anesthesia ,Injections, Intravenous ,Female ,Neurology (clinical) ,medicine.symptom ,business ,Magnetic Resonance Angiography ,Fibrinolytic agent - Abstract
Background and purpose Intravenous administration of tissue plasminogen activator (t-PA) can improve clinical outcomes in patients with acute ischemic stroke. The most important complication of t-PA therapy is intracerebral hemorrhage (ICH). The aim of this study was to use serial MRI studies to identify independent predictors of symptomatic and asymptomatic ICH after t-PA therapy. Methods Consecutive anterior-circulation ischemic stroke patients treated with t-PA within 3 h of stroke onset were studied prospectively. To identify the presence of recanalization in the occluded arteries and the presence of ICH, MRI, including diffusion weighted imaging (DWI), T2*, and magnetic resonance angiography (MRA), was performed before and 1 h, 24 h, and 5–7 days after t-PA thrombolysis. The independent predictors of ICH were determined using multivariate logistic regression analysis. Results 41 patients (21 males, 20 females; mean age, 73.2 ± 10.7 years) were enrolled, and 19 ICHs (1 symptomatic, 18 asymptomatic) were observed on T2*. The initial MRA demonstrated occluded brain arteries in 31 patients (75.6%), of which follow-up MRA at 1 h, 24 h, and 5–7 days after t-PA therapy revealed recanalization in 48.4%, 80.0%, and 90.0% of patients, respectively. The frequency of recanalization within 1 h after t-PA therapy did not differ between ICH and No-ICH groups, but the ICH group had more frequent recanalization between 1 h and 24 h after t-PA than the No-ICH group (50.0% vs. 4.5%, P = 0.001). The ICH group had arterial fibrillation (AF) more frequently than the No-ICH group (78.9% vs. 27.3%, P = 0.001). Compared to the No-ICH group, the NIHSS score was higher (16.4 ± 5.7 vs. 11.5 ± 6.5, P = 0.011) and the ASPECTS–DWI value (a normal DWI has an ASPECTS–DWI value of 11 points) was lower (7.3 ± 2.4 vs. 8.9 ± 1.9, P = 0.019) in the ICH group. Multivariate logistic regression analysis demonstrated that the presence of recanalization between 1 and 24 h after the end of t-PA infusion (OR: 20.2; CI: 1.0–340.9; P = 0.037) was the only independent predictor of ICH. Conclusion Recanalization of occluded arteries between 1 and 24 h but not within 1 h after t-PA infusion should be independently associated with symptomatic and asymptomatic ICH after t-PA therapy.
- Published
- 2008
- Full Text
- View/download PDF